BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Maula Bux on June 19, 2014 and is headquartered in Richmond, Canada.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of BioMark Diagnostics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. BioMark Diagnostics Inc market cap is $35.73M.
What is the 52-week high for BioMark Diagnostics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioMark Diagnostics Inc 52 week high is $0.375 as of September 07, 2025.
What is the 52-week low for BioMark Diagnostics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioMark Diagnostics Inc 52 week low is $0.18 as of September 07, 2025.
What is BioMark Diagnostics Inc stock price today?
BioMark Diagnostics Inc stock price today is $0.34.
What was BioMark Diagnostics Inc stock price yesterday?
BioMark Diagnostics Inc stock price yesterday was $0.32.
What is the PE ratio of BioMark Diagnostics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. BioMark Diagnostics Inc’s P/E ratio is -19.21.
What is the Price-to-Book ratio of BioMark Diagnostics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. BioMark Diagnostics Inc P/B ratio is 26.8350.
What is the 50-day moving average of BioMark Diagnostics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. BioMark Diagnostics Inc 50-day moving average is $0.3439.